Molecular mechanisms of insulin signal transduction and diabetes mellitus
胰岛素信号转导与糖尿病的分子机制
基本信息
- 批准号:10470032
- 负责人:
- 金额:$ 8.19万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
One of the down stream effectors of P13-kinase is serine-threonine kinase Akt (protein kinase B, RAK-PK), but the involvement of Akt in insulin-stimulated GLUT4 translocation is controversial. To investigate whether Akt 1 regulates insulin-stimulated GLUT4 translocation and glucose uptake in L6 myotubes, we established L6 myotubes stably expressing c-myc epitope-tagged GLUT4 (GLUT4myc) and mouse wild type (WT) Akt 1 . We found that overexpression of WT Akt 1 promoted insulin-stimulated p70S6 kinase (p70S6K) activity and increased the basal activity of GSK3β, but did not promote insulin-stimulated GLUT4 translocation or glucose uptake. These data supported the result that Akt is not a main signaling molecule to transmit the signal of insulin-stimulated GLUT4 translocation or glucose uptake from insulin-activated P13-kinase. To define the effect of platelet-derived growth factor (PDGF) on glucose transport in 3T3-L1 adipocytes, we investigated the PDGF- and insulin-induced glucose uptake … More , translocation of glucose transporters and PI 3-kinase activity in 3T3-L1, 3T3-L1GLUT4myc and 3T3-L1GLUT1myc adipocytes. Insulin and PDGF stimulated glucose uptake by 9-10 and 5.5-6.5-fold, respectively, in both 3T3-L1 and 3T3-L1GLUT4myc adipocytes. Exogenous GLUT4myc expression led to enhanced PDGF-induced glucose transport. In 3T3-L1GLUT4myc adipocytes, insulin and PDGF induced an 8-fold and 5-fold increase in GLUT4myc translocation, respectively, determined in a cell surface anti-c-myc antibody binding assay. This PDGF-induced GLUT4myc translocation was further demonstrated with fluorescent detection. In contrast, PDGF stimulated a 2-fold increase of GLUT1myc translocation and 2.5-fold increase of glucose uptake in 3T3-L1GLUT1myc adipocytes. The PDGF-induced GLUT4myc translocation, glucose uptake and PI 3-kinase activity were maximal(100%) at 5-10 mm, and thereafter rapidly declined to 40, , and 12%, respectively, within 60 mm, a time when effects of insulin were maximal. Wortmannin (0.1 μM) abolished PDGF-induced GLUT4myc translocation and glucose uptake in 3T3-L1GLUT4myc adipocytes. These results suggest that PDGF can transiently trigger the translocation of GLUT4 and stimulates glucose uptake by translocation of both GLUT4 and GLUT 1 in a phosphatidylinositol 3-kinase-dependent signaling pathway in 3T3-L1 adipocytes. Less
丝氨酸-苏氨酸激酶Akt(protein kinase B,RAK-PK)是P13-激酶的下游效应子之一,但Akt是否参与胰岛素刺激的GLUT 4易位仍存在争议。为了研究Akt 1是否调节L 6肌管中胰岛素刺激的GLUT 4易位和葡萄糖摄取,我们建立了稳定表达c-myc表位标记的GLUT 4(GLUT 4 myc)和小鼠野生型(WT)Akt 1的L 6肌管。我们发现WT Akt 1的过表达促进了胰岛素刺激的p70 S6激酶(p70 S6 K)活性,并增加了GSK 3 β的基础活性,但不促进胰岛素刺激的GLUT 4易位或葡萄糖摄取。这些数据支持Akt不是胰岛素刺激的GLUT 4转位或胰岛素激活的P13-激酶摄取葡萄糖信号的主要信号分子的结果。为了明确血小板衍生生长因子(PDGF)对3 T3-L1脂肪细胞葡萄糖转运的影响,我们研究了PDGF和胰岛素诱导的葡萄糖摄取 ...更多信息 3 T3-L1、3 T3-L1 GLUT 4 myc和3 T3-L1 GLUT 1 myc脂肪细胞中葡萄糖转运蛋白转位和PI 3-激酶活性。在3 T3-L1和3 T3-L1 GLUT 4 myc脂肪细胞中,胰岛素和PDGF分别刺激葡萄糖摄取9-10倍和5.5-6.5倍。外源性GLUT 4 myc表达增强PDGF诱导的葡萄糖转运。在3 T3-L1 GLUT 4 myc脂肪细胞中,胰岛素和PDGF分别诱导GLUT 4 myc易位增加8倍和5倍,在细胞表面抗c-myc抗体结合试验中测定。用荧光检测进一步证实了PDGF诱导的GLUT 4 myc易位。相反,PDGF刺激3 T3-L1 GLUT 1 myc脂肪细胞中GLUT 1 myc易位增加2倍,葡萄糖摄取增加2.5倍。PDGF诱导的GLUT 4 myc易位、葡萄糖摄取和PI 3-激酶活性在5-10 mm时达到最大(100%),此后迅速下降,在60 mm内分别为40%和12%,此时胰岛素的作用最大。Wortmannin(0.1 μM)可阻断PDGF诱导的3 T3-L1 GLUT 4 myc脂肪细胞中GLUT 4 myc易位和葡萄糖摄取。这些结果表明,PDGF可以瞬时触发GLUT 4的易位,并通过在3 T3-L1脂肪细胞中的磷脂酰肌醇3-激酶依赖性信号通路中的GLUT 4和GLUT 1两者的易位来刺激葡萄糖摄取。少
项目成果
期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takanobu Imanaka,Yousuke Ebina,et al.: "Reconatitution of Insulin Signaling Pathways in Rat 3Y1 Cells Lacking Insulin Receptor and Insulin Receptor Substrate-1" J.Biol.Chem.273. 25347-25355 (1998)
Takanobu Imanaka、Yousuke Ebina 等人:“缺乏胰岛素受体和胰岛素受体底物 1 的大鼠 3Y1 细胞中胰岛素信号通路的重建”J.Biol.Chem.273。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takanobu Imanaka,Yousuke Ebina,et al.: "Reconatitution of Insulin Signaling Pathways in Rat 3YI Cells Lacking Insulin Receptor and Insulin Receptor Substrate-1"J.Biol.Chem.. 273. 25347-25355 (1998)
Takanobu Imanaka、Yousuke Ebina 等:“缺乏胰岛素受体和胰岛素受体底物 1 的大鼠 3YI 细胞中胰岛素信号通路的重建”J.Biol.Chem.. 273. 25347-25355 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Atsunori Ueyama Yousuke Ebina,et al.: "GLUT-4myc ectopic expression in L6 myoblasts generates a GLUT-4-specific pool conferring insulin sensitivity"Am.J.Physiol. 277. E572-E578 (1999)
Atsunori Ueyama Yousuke Ebina 等人:“L6 成肌细胞中的 GLUT-4myc 异位表达产生了赋予胰岛素敏感性的 GLUT-4 特异性库”Am.J.Physiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kazuhiro Kishi,Yousuke Ebina, et al.: "Bradykinin directly triggers GLUT4 translocation via an insulin-independent pathway"Diabetes. 47. 550-558 (1998)
Kazuhiro Kishi、Yousuke Ebina 等人:“缓激肽通过独立于胰岛素的途径直接触发 GLUT4 易位”糖尿病。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takamobu Imanaka, Yousuke Ebina, et al.: "Reconstitution of Insulin Signaling Pathways in Rat 3Y1 Cells Lacking Insulin Receptor and Insulin Receptor Substrate-1"J. Biol. Chem.. 273. 25347-25355 (1998)
Takamobu Imanaka、Yousuke Ebina 等人:“缺乏胰岛素受体和胰岛素受体底物 1 的大鼠 3Y1 细胞中胰岛素信号通路的重建”J。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EBINA Yousuke其他文献
EBINA Yousuke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EBINA Yousuke', 18)}}的其他基金
Is insulin inactivated by the binding with serum soluble insulin receptor(sIR)?
胰岛素是否会因与血清可溶性胰岛素受体(sIR)结合而失活?
- 批准号:
23659156 - 财政年份:2011
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Molecular mechanisms of Insulin signal transduction and diabetes mellitus
胰岛素信号转导与糖尿病的分子机制
- 批准号:
20390095 - 财政年份:2008
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of insulin signal transduction and diabetes mellitus
胰岛素信号转导与糖尿病的分子机制
- 批准号:
18390104 - 财政年份:2006
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of insulin signal transduction and diabetes mellitus
胰岛素信号转导与糖尿病的分子机制
- 批准号:
16390097 - 财政年份:2004
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of insulin signal transduction and diabetes mellitus
胰岛素信号转导与糖尿病的分子机制
- 批准号:
14370045 - 财政年份:2002
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a drug for diabetes using human genome information
利用人类基因组信息开发糖尿病药物
- 批准号:
13557011 - 财政年份:2001
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of insulin signal transduction and diabetas mellitus
胰岛素信号转导与糖尿病的分子机制
- 批准号:
12470027 - 财政年份:2000
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a simple screening system for the discovery of a new drug for diabetes
开发用于发现糖尿病新药的简单筛选系统
- 批准号:
10557019 - 财政年份:1998
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Development of a simple screening system for the discovery of a new drug for diabetes
开发用于发现糖尿病新药的简单筛选系统
- 批准号:
08558074 - 财政年份:1996
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Molecular mechanisms of insulin signal transduction and diabetes mellitus
胰岛素信号转导与糖尿病的分子机制
- 批准号:
08457050 - 财政年份:1996
- 资助金额:
$ 8.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
PI3 Kinase Inactivation in Myelodysplastic Syndrome
骨髓增生异常综合征中的 PI3 激酶失活
- 批准号:
10518821 - 财政年份:2022
- 资助金额:
$ 8.19万 - 项目类别:
PI3 Kinase Inactivation in Myelodysplastic Syndrome
骨髓增生异常综合征中的 PI3 激酶失活
- 批准号:
10669279 - 财政年份:2022
- 资助金额:
$ 8.19万 - 项目类别:
PI3 Kinase Inactivation in Myelodysplastic Syndrome
骨髓增生异常综合征中的 PI3 激酶失活
- 批准号:
10476196 - 财政年份:2021
- 资助金额:
$ 8.19万 - 项目类别:
Targeting PI3-kinase p110delta to treat Crohn's disease-associated intestinal fibrosis
靶向 PI3 激酶 p110delta 治疗克罗恩病相关肠纤维化
- 批准号:
401340 - 财政年份:2019
- 资助金额:
$ 8.19万 - 项目类别:
Operating Grants
Development of a Dual and Selective Small Molecule Inhibitor of EGFR and PI3 Kinase to Treat BRAF Mutant Colorectal Cancer
开发 EGFR 和 PI3 激酶双重选择性小分子抑制剂来治疗 BRAF 突变结直肠癌
- 批准号:
10377535 - 财政年份:2018
- 资助金额:
$ 8.19万 - 项目类别:
Development of a Dual and Selective Small Molecule Inhibitor of EGFR and PI3 Kinase to Treat BRAF Mutant Colorectal Cancer
开发 EGFR 和 PI3 激酶双重选择性小分子抑制剂来治疗 BRAF 突变结直肠癌
- 批准号:
9896781 - 财政年份:2018
- 资助金额:
$ 8.19万 - 项目类别:
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
膜运输和代谢中的 PI3 激酶 PIK3CB (p110beta)
- 批准号:
10001471 - 财政年份:2018
- 资助金额:
$ 8.19万 - 项目类别:
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
膜运输和代谢中的 PI3 激酶 PIK3CB (p110beta)
- 批准号:
10474502 - 财政年份:2018
- 资助金额:
$ 8.19万 - 项目类别:
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
膜运输和代谢中的 PI3 激酶 PIK3CB (p110beta)
- 批准号:
10249278 - 财政年份:2018
- 资助金额:
$ 8.19万 - 项目类别:
Endothelial Healing is Inhibited by PI3 Kinase-Induced Activation of TRPC6
PI3 激酶诱导的 TRPC6 激活抑制内皮愈合
- 批准号:
10265334 - 财政年份:2017
- 资助金额:
$ 8.19万 - 项目类别: